Integrative omics approaches to advance rare disease diagnostics.
J. Inherit. Metab. Dis. 46, 824-838 (2023)
Over the past decade high-throughput DNA sequencing approaches, namely whole exome and whole genome sequencing became a standard procedure in Mendelian disease diagnostics. Implementation of these technologies greatly facilitated diagnostics and shifted the analysis paradigm from variant identification to prioritisation and evaluation. The diagnostic rates vary widely depending on the cohort size, heterogeneity and disease and range from around 30% to 50% leaving the majority of patients undiagnosed. Advances in omics technologies and computational analysis provide an opportunity to increase these unfavourable rates by providing evidence for disease-causing variant validation and prioritisation. This review aims to provide an overview of the current application of several omics technologies including RNA-sequencing, proteomics, metabolomics and DNA-methylation profiling for diagnostics of rare genetic diseases in general and inborn errors of metabolism in particular.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Rna Sequencing ; Episignatures ; Methylomics ; Multi-omics ; Proteomics ; Rare Genetic Disorders; Dna Methylation Signature; Human Phenotype Ontology; Mitochondrial Complex; Inborn-errors; Identification; Transcriptome; Variants; Genes; Association; Reanalysis
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2023
Prepublished im Jahr
0
HGF-Berichtsjahr
2023
ISSN (print) / ISBN
0141-8955
e-ISSN
1573-2665
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 46,
Heft: 5,
Seiten: 824-838
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Springer
Verlagsort
111 River St, Hoboken 07030-5774, Nj Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-503292-001
Förderungen
We would like to thank the Prokisch lab members for the constructive discussions on the future applications of multi-omics in molecular diagnostics. Open Access funding enabled and organized by Projekt DEAL.
Copyright
Erfassungsdatum
2023-10-06